MARC record from Internet Archive

LEADER: 07803cam 2200817Ia 4500
001 ocn324993373
003 OCoLC
005 20200520215404.0
008 090518s2006 paua ob 001 0 eng d
006 m o d
007 cr cn|||||||||
040 $aOPELS$beng$epn$cOPELS$dOPELS$dOCLCQ$dOCLCE$dOCLCQ$dOCLCO$dKOS$dOPELS$dU9S$dOPELS$dOCLCF$dOPELS$dWAU$dOCLCQ$dYDXCP$dOCLCQ$dOCLCO$dOCLCA$dUAB$dOCLCQ$dADU
019 $a489081185$a607665384$a649999610$a974619113$a1027317970$a1058900632$a1096213236$a1102021354$a1113255071$a1119401226
020 $z9780323070553
020 $z0323070558
020 $z0323034373
020 $z9780323034371
035 $a(OCoLC)324993373$z(OCoLC)489081185$z(OCoLC)607665384$z(OCoLC)649999610$z(OCoLC)974619113$z(OCoLC)1027317970$z(OCoLC)1058900632$z(OCoLC)1096213236$z(OCoLC)1102021354$z(OCoLC)1113255071$z(OCoLC)1119401226
037 $a179049:176011$bElsevier Science & Technology$nhttp://www.sciencedirect.com
042 $adlr
050 4 $aRC931.O73$bO88 2006
060 4 $a2006 J-418
060 4 $aWE 250$bO85116 2006
082 04 $a616.7/16$222
245 00 $aOsteoporosis and the osteoporosis of rheumatic diseases :$ba companion to Rheumatology /$c[editors] Nancy E. Lane, Philip N. Sambrook.
250 $a1st ed.
260 $aPhiladelphia :$bMosby/Elsevier,$c©2006.
300 $a1 online resource (xvi, 289 pages) :$billustrations (some color)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
504 $aIncludes bibliographical references and index.
588 0 $aPrint version record.
505 0 $aA. Epidemiology -- 1. Epidemiology of Osteoporosis (women, men, children) -- 2. Genetics of Osteoporosis -- 3. Peak Bone Mass Acquisition -- 4. Who Should we Treat for Osteoporosis? -- B. Pathogenetic Mechanisms -- -- 1. The Pathogenesis of Osteoporosis- A Disease of Bone Remodeling -- 2. Biomechanics of Bone -- 3. Animal Models and Implications for Therapy -- 4. The Bone Biopsy- What Information Can We Obtain -- C. Clinical Aspects of the Disease -- 1. The Patient with Osteoporosis -- 2. Clinical Application of the Measurement of Bone Mass a. DXA b. QCT -- c. Peripheral measurements (pDXA, ultrasound) -- d. MRI -- 3. Bone Turnover Markers -- a. Their Place in the Investigation of Osteoporosis -- b. The Evaluation of Bone Turnover Markers for Fracture Risk and Treatment -- 4. The Evaluation of the Patient for Osteoporosis- Using the Diagnostic Tests for Treatment Interventions. -- -- D. Treatment of the Disease (*All chapters cover both the science and the therapy in the prevention and treatment of osteoporosis) -- 1. Exercise in the Prevention of Osteoporotic Fractures -- 2. Calcium in the Prevention and Treatment of Osteoporosis -- 3. Vitamin D and its Metabolites in the Prevention and Treatment of Osteoporosis -- 4. Statins -- 5. Estrogen/SERMs- The Science and the Therapy in Prevention and Treatment of Osteoporosis -- 6. Androgens, Gonadal Steroids in Bone Health -- 7. Calcitonin: The Science and Clinical Utilization -- 8. Bisphosphonates: The Science and the Therapy in the Prevention and Treatment of Osteoporosis -- 9. PTH: The Science and the Therapy in the Treatment of Osteoporosis -- 10. Combination therapy for Osteoporosis- What does the Data Show Us -- E. Non-medical Treatment of Osteoporosis -- 1. The Disability Associated with Osteoporosis -- 2. The Rehabilitation of patients with Osteoporosis and Fractures -- 3. The Treatment of Osteoporotic Fractures- The Surgical Perspective -- F. Glucocorticoid-Induced Osteoporosis -- 1. The Pathogenesis of Glucocorticoid-Induced Bone Loss -- 2. The Prevention and Treatment of Glucocorticoid-Induced Bone Loss -- G. Transplantation-Induced Osteoporosis -- 1. The Pathogenesis of Transplant-Induced Bone Loss -- 2. The Prevention and Treatment of Transplantation Induced Bone Loss -- H. Osteoporosis and the Rheumatic Diseases -- 1. Epidemiology of Osteoporosis in RA, SLE, AS -- 2. The Pathogenesis of Inflammatory Induced Bone Loss -- 3. The Prevention and Treatment of Inflammatory Induced Bone Loss-Can it Be Done.
520 $aGet new insights into the causes, detection and therapy of osteoporosis and the osteoporosis of rheumatic diseases. In this state-of-the-art resource, you'll find coverage of all the latest scientific and clinical developments, new concepts in epidemiology, cutting-edge information on genetics and pathogenic mechanisms, current developments in diagnostic interventions and prevention, and the very latest techniques in treatment. This is a must-have reference for comprehensive, one-stop coverage of Osteoporosis. Allows planning of early interventions, as appropriate, to augment peak adult bone mass. Highlights the necessary tools for early diagnosis, and monitoring of disease progression. Discusses the very latest in pharmacologic interventions, including biophosphonates, SERMS, and osteoanabolic agents. Provides access to the latest information on disease modifying or disease controlling biologic agents. Incorporates the latest on glucocorticoid and transplantation- induced osteoporosis, as well as osteoporosis in the rheumatic diseases.
506 $3Use copy$fRestrictions unspecified$2star$5MiAaHDL
533 $aElectronic reproduction.$b[Place of publication not identified] :$cHathiTrust Digital Library,$d2010.$5MiAaHDL
538 $aMaster and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.$uhttp://purl.oclc.org/DLF/benchrepro0212$5MiAaHDL
583 1 $adigitized$c2010$hHathiTrust Digital Library$lcommitted to preserve$2pda$5MiAaHDL
650 0 $aOsteoporosis.
650 0 $aRheumatism$xComplications.
650 12 $aOsteoporosis.
650 22 $aRheumatic Diseases$xcomplications.
650 6 $aOstéoporose.
650 6 $aRhumatisme$xComplications et séquelles.
650 7 $aOsteoporosis.$2fast$0(OCoLC)fst01048817
650 7 $aRheumatism$xComplications.$2fast$0(OCoLC)fst01097005
650 7 $aOstéoporose.$2ram
650 7 $aRhumatisme$xComplications.$2ram
655 4 $aElectronic books.
700 1 $aLane, Nancy E.
700 1 $aSambrook, Philip.
730 0 $aRheumatology.
776 08 $iPrint version:$tOsteoporosis and the osteoporosis of rheumatic diseases.$b1st.$dPhiladelphia : Mosby/Elsevier, ©2006$z0323034373$z9780323034371$w(DLC) 2005058428$w(OCoLC)62787311
856 40 $3ClinicalKey$uhttp://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-B9780323034371X50015
856 40 $3ClinicalKey$uhttp://www.clinicalkey.com.au/dura/browse/bookChapter/3-s2.0-B9781416022466X50019
856 40 $3ClinicalKey$uhttps://www.clinicalkey.com.au/dura/browse/bookChapter/3-s2.0-B9780323034371X50015
856 40 $3Google$uhttp://books.google.com/books?id=wwhsAAAAMAAJ
856 40 $3HathiTrust Digital Library, Limited view (search only)$uhttp://catalog.hathitrust.org/api/volumes/oclc/62787311.html
856 40 $3MD Consult$uhttp://www.mdconsult.com/public/book/view?title=Osteoporosis+and+the+Osteoporosis+of+Rheumatic+Diseases
856 40 $3ScienceDirect$uhttps://www.sciencedirect.com/science/book/9780323034371
856 40 $zAvailable from ScienceDirect. Online version available for university members only. This requires an institutional login off-campus.$uhttp://www.sciencedirect.com/science/book/9780323034371
938 $aYBP Library Services$bYANK$n12232972
029 1 $aCHBIS$b007226759
029 1 $aCHVBK$b18196726X
029 1 $aDEBBG$bBV039833420
029 1 $aDEBBG$bBV042310474
029 1 $aDEBSZ$b407388052
029 1 $aNZ1$b15194853
994 $aZ0$bP4A
948 $hHELD BY P4A - 276 OTHER HOLDINGS